Modulation of cell proliferation and cell cycle regulators by vitamin E in human prostate carcinoma cell lines

被引:72
作者
Venkateswaran, V [1 ]
Fleshner, NE [1 ]
Klotz, LH [1 ]
机构
[1] Sunnybrook & Womens Coll, Hlth Sci Ctr, Div Urol, Toronto, ON, Canada
关键词
prostate; prostatic neoplasms; antioxidants; vitamin E; cell cycle;
D O I
10.1016/S0022-5347(05)64524-7
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Vitamin E has been identified as a candidate agent for the prevention of prostate cancer. We hypothesize that the mechanism for this effect is in part a result of cell cycle inhibition rather than only due to a reduction in reactive oxygen species. We tested whether vitamin K induces cell cycle arrest in prostate carcinoma, mediated by alterations in cell cycle regulatory proteins, including cyclin E, cdk2 and p27. Materials and Methods: Cells were incubated with and without vitamin E (alpha-tocopherol succinate, 20 mug./ml.), fixed and stained with propidium. iodide for flow cytometry analysis. In parallel experiments total protein was extracted, immunoprecipitated with cyclin E antibody and analyzed by Western blot for the expression of cell cycle markers. Results: Flow cytometry analysis revealed a dramatic reduction in the S phase percent of LNCaP and PC3 cells in response to vitamin E (69% and 95%, respectively). It was accompanied by over expression of p27 (3-fold increase) with vitamin E treatment. Conclusions: This study demonstrates that at physiological concentrations vitamin E induced profound cell cycle arrest mediated by up-regulation of p27. This observation provides a theoretical basis for the putative chemopreventive effect of vitamin E.
引用
收藏
页码:1578 / 1582
页数:5
相关论文
共 23 条
[1]   Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents [J].
Agarwal, R .
BIOCHEMICAL PHARMACOLOGY, 2000, 60 (08) :1051-1059
[2]   OXIDANTS, ANTIOXIDANTS, AND THE DEGENERATIVE DISEASES OF AGING [J].
AMES, BN ;
SHIGENAGA, MK ;
HAGEN, TM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (17) :7915-7922
[3]   Decreased levels of the cell-cycle inhibitor p27(Kip1) protein: Prognostic implications in primary breast cancer [J].
Catzavelos, C ;
Bhatacharya, N ;
Ung, YC ;
Wilson, JA ;
Roncari, L ;
Sandhu, C ;
Shaw, P ;
Yeger, H ;
MoravaProtzner, I ;
Kapusta, L ;
Franssen, E ;
Pritchard, KI ;
Slingerland, JM .
NATURE MEDICINE, 1997, 3 (02) :227-230
[4]   Requirement of p27(Kip1) for restriction point control of the fibroblast cell cycle [J].
Coats, S ;
Flanagan, WM ;
Nourse, J ;
Roberts, JM .
SCIENCE, 1996, 272 (5263) :877-880
[5]   VITAMIN-E SUCCINATE POTENTIATES THE INHIBITORY EFFECT OF PROSTAGLANDINS ON ORAL SQUAMOUS CARCINOMA CELL-PROLIFERATION [J].
ELATTAR, TMA ;
LIN, HS .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1995, 52 (01) :69-73
[6]   Vitamin E inhibits the high-fat diet promoted growth of established human prostate LNCaP tumors in nude mice [J].
Fleshner, N ;
Fair, WR ;
Huryk, R ;
Heston, WDW .
JOURNAL OF UROLOGY, 1999, 161 (05) :1651-1654
[7]  
Fleshner Neil E., 1997, Journal of Urology, V157, P110
[8]   INTAKE OF CAROTENOIDS AND RETINOL IN RELATION TO RISK OF PROSTATE-CANCER [J].
GIOVANNUCCI, E ;
ASCHERIO, A ;
RIMM, EB ;
STAMPFER, MJ ;
COLDITZ, GA ;
WILLETT, WC .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (23) :1767-1776
[9]  
Gunawardena K, 2000, PROSTATE, V44, P287, DOI 10.1002/1097-0045(20000901)44:4&lt
[10]  
287::AID-PROS5&gt